眼压下降不影响高眼压症患者眼动脉血流率
该研究纳入30例未治疗的高眼压症患者,采用3T磁共振相衬成像测量眼动脉血流率,受试眼每日一次拉坦前列素、对侧眼为对照,约1周后复查。结果显示拉坦前列素使受试眼眼压下降7.2±3.1 mmHg(P<0.01),但受试眼与对照眼的眼动脉血流率在治疗前后均无显著变化。提示眼压显著下降不影响高眼压症患者眼动脉血流率。
要点
- 拉坦前列素使受试眼眼压下降7.2±3.1 mmHg(P<0.01),眼动脉血流率无显著变化。
- 受试眼治疗前后眼动脉血流率分别为12.4±4.4与12.4±4.6 mL/min(P=0.92)。
- 对照眼治疗前后眼动脉血流率分别为13.5±5.2与13.4±4.1 mL/min(P=0.92)。
核心结论
- 眼压显著下降不影响高眼压症患者眼动脉的血流率。
- 维持眼供血不依赖眼压可能是高眼压症患者保护视功能的机制。
研究设计与样本
- 研究纳入30例未治疗的高眼压症患者,平均年龄67±8岁,其中女性14例。
- 受试者接受眼科检查及3-Tesla磁共振成像,包括三维高分辨率相衬磁共振成像测量眼动脉血流率。
- 受试眼每日一次拉坦前列素,对侧眼为对照,约1周后重复相同测量。
主要发现
- 受试眼眼动脉血流率治疗前后分别为12.4±4.4与12.4±4.6 mL/min(P=0.92)。
- 对照眼眼动脉血流率治疗前后分别为13.5±5.2与13.4±4.1 mL/min(P=0.92)。
- 受试眼与对照眼血流率在治疗前(P=0.13)或治疗后(P=0.18)均无显著差异。
- 治疗后血流率变化在受试眼与对照眼间无显著差异(0.1±3.1 vs. -0.1±4.0 mL/min,P=0.84)。
- 拉坦前列素使受试眼眼压下降7.2±3.1 mm Hg(P<0.01)。
临床怎么用
- 在高眼压症患者中,拉坦前列素降眼压治疗未伴随眼动脉血流率改变,解读眼血流指标时需考虑此现象。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate if decrease of IOP affects the volumetric blood flow rate in the ophthalmic artery (OA) in patients with previously untreated ocular hypertension. METHODS: Subjects with untreated ocular hypertension (n = 30; mean age 67 ± 8 years; 14 females) underwent ophthalmologic examination and a 3-Tesla magnetic resonance imaging investigation. The magnetic resonance imaging included three-dimensional high-resolution phase-contrast magnetic resonance imaging to measure the OA blood flow rate. The subjects received latanoprost once daily in the eye with higher pressure, the untreated eye served as control. The same measurements were repeated approximately 1 week later. RESULTS: The mean OA blood flow rate before and after treatment was 12.4 ± 4.4 and 12.4 ± 4.6 mL/min in the treated eye (mean ± SD; P = 0.92) and 13.5 ± 5.2 and 13.4 ± 4.1 mL/min in the control eye (P = 0.92). There was no significant difference between the treated and control eye regarding blood flow rate before (P = 0.13) or after treatment (P = 0.18), or change in blood flow rate after treatment (0.1 ± 3.1 vs. -0.1 ± 4.0 mL/min, P = 0.84). Latanoprost decreased the IOP by 7.2 ± 3.1 mm Hg in the treated eye (P < 0.01). CONCLUSIONS: The results indicate that a significant lowering of IOP does not affect the blood flow rate of the OA in ocular hypertension subjects. The ability to maintain blood supply to the eye independent of the IOP could be a protective mechanism in preserving vision in subjects with ocular hypertension.
引用
- Jóhannesson G, Qvarlander S, Wåhlin A, et al. Intraocular Pressure Decrease Does Not Affect Blood Flow Rate of Ophthalmic Artery in Ocular Hypertension. Invest Ophthalmol Vis Sci. 2020. PMID: 33074299. doi:10.1167/iovs.61.12.17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。